News
THOXF
0.750
NaN%
--
Weekly Report: what happened at THOXF last week (0908-0912)?
Weekly Report · 09/15/2025 09:35
Weekly Report: what happened at THOXF last week (0901-0905)?
Weekly Report · 09/08/2025 09:36
Weekly Report: what happened at THOXF last week (0825-0829)?
Weekly Report · 09/01/2025 09:34
Weekly Report: what happened at THOXF last week (0818-0822)?
Weekly Report · 08/25/2025 09:37
Weekly Report: what happened at THOXF last week (0811-0815)?
Weekly Report · 08/18/2025 09:35
Weekly Report: what happened at THOXF last week (0804-0808)?
Weekly Report · 08/11/2025 09:37
Weekly Report: what happened at THOXF last week (0728-0801)?
Weekly Report · 08/04/2025 09:38
Weekly Report: what happened at THOXF last week (0721-0725)?
Weekly Report · 07/28/2025 09:38
Weekly Report: what happened at THOXF last week (0714-0718)?
Weekly Report · 07/21/2025 09:36
Weekly Report: what happened at THOXF last week (0707-0711)?
Weekly Report · 07/14/2025 09:37
Weekly Report: what happened at THOXF last week (0630-0704)?
Weekly Report · 07/07/2025 09:36
Weekly Report: what happened at THOXF last week (0623-0627)?
Weekly Report · 06/30/2025 09:37
Weekly Report: what happened at THOXF last week (0616-0620)?
Weekly Report · 06/23/2025 09:35
Weekly Report: what happened at THOXF last week (0609-0613)?
Weekly Report · 06/16/2025 09:37
Weekly Report: what happened at THOXF last week (0602-0606)?
Weekly Report · 06/09/2025 09:38
Weekly Report: what happened at THOXF last week (0526-0530)?
Weekly Report · 06/02/2025 09:40
Weekly Report: what happened at THOXF last week (0519-0523)?
Weekly Report · 05/26/2025 09:39
More
Webull provides a variety of real-time THOXF stock news. You can receive the latest news about Bioporto As through multiple platforms. This information may help you make smarter investment decisions.
About THOXF
Bioporto A/S is a Denmark-based company engaged in the development and marketing of in vitro diagnostic (IVD) assays. The Company’s portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test for diagnosing acute kidney injury; NGAL Enzyme-linked immunosorbent assay (ELISA) kits, which supplies NGAL for the development of medicines for estimating side-effects that are harmful to kidneys; Mannan-binding Lectin (MBL) ELISA kit, which offers monoclonal MBL antibodies that are responsible for the activation of immune response; Antibodies, including monoclonal antibodies used in a range of research areas, such as microbiology, biomarkers, peptide hormones and plasma proteins; and Activated Protein C with Protein C Inhibitor Complex (APC-PCI), a biomarker applied to patients with sepsis and thrombotic and hemostatic disorders. In addition, the Company is a parent of BioPorto Diagnostics A/S.